Skip to main content

Local Anesthesia News

Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010

FRIDAY, July 25, 2025 – Local anesthetic poisoning reports decreased following publication of advisories in 2010, but reports of lidocaine poisoning and mortality have increased, according to a...

No Link Found for Preprocedural Fasting and Witnessed Pulmonary Aspiration

WEDNESDAY, July 2, 2025 – For patients undergoing surgical procedures, there is no association between liberal preprocedural fasting policies and witnessed aspiration, according to a systematic...

Guidelines Developed to Address Infections Tied to Regional Anesthesia

THURSDAY, Jan. 30, 2025 – In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and published online Jan. 20 in Regional Anesthesia & Pain Medicine,...

American Society of Anesthesiologists, Oct. 18 to 22

The annual meeting of the American Society of Anesthesiologists was held from Oct. 18 to 22 in Philadelphia, attracting approximately 5,000 participants from around the world, including a...

St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry

FORT COLLINS, Colo., July 12, 2016 /PRNewswire/ – St. Renatus, LLC, a privately held company based in Fort Collins, Colorado, is pleased to announce it received U.S. Food and Drug Administration...

FDA Medwatch Alert: Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter

ISSUE: Fresenius Kabi USA announced today it is voluntarily recalling a single lot (Lot Number 6111504; Product Code 470237) of Sensorcaine®-MPF (bupivacaine HCl) Injection, USP, 0.75%, 7.5 mg/mL, 30 ...

FDA Medwatch Alert: Bupivacaine HCl Injection by Hospira: Recall - Iron Oxide Particulate In Glass Vials

ISSUE: Hospira issued a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection, USP, 0.5% (5 mg/mL), 30 mL Single-dose (NDC: 0409-1162-02, Lot 38-515-DK, Expiry 1FEB2016) due to...

FDA Medwatch Alert: Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter

ISSUE: Hospira announced it will initiate a voluntary recall of one lot of 1% Lidocaine HCI for Injection, USP, 10 mg per mL, 30 mL Single-dose, Preservative-Free to the user level due to a confirmed...

FDA Medwatch Alert: Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free Vial: Recall - Visible Particulates

[Posted 06/18/2014] ISSUE: Hospira announced a voluntary nationwide recall to the user level for one lot of 0.5% Marcaine (Bupivacaine HCl Injection, USP), 30 mL, Single-dose Vial – Preservative F...

FDA Medwatch Alert: Compounded topical anesthetic creams

[Posted 12/06/2006] FDA notified healthcare professionals and consumers about the serious public health risks related to compounded topical anesthetic creams. FDA issued warning letters to five firms...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Anesthesia